News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mulroy Michael H.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.41, valued at
$70.5k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2022 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Bought 7,000 shares
@ $1.4, valued at
$9.8k
|
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 40,000 options to buy
@ $1.03, valued at
$41.2k
|
|
| 03/15/2019 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 194,271 shares
@ $0 |
|
| 03/13/2019 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 65,000 options to buy
@ $4.28, valued at
$278.2k
|
|
| 03/05/2019 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 252,606 shares
@ $0
Paid exercise price by delivering 76,588 shares
@ $0.95, valued at
$72.8k
|
|
| 08/29/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 3,141 shares
@ $1.5918, valued at
$5k
|
|
| 07/27/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,950 shares
@ $1.6949, valued at
$5k
|
|
| 07/03/2018 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 40,000 options to buy
@ $2.06, valued at
$82.4k
|
|
| 06/27/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 3,067 shares
@ $1.63, valued at
$5k
|
|
| 05/31/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 3,153 shares
@ $1.5857, valued at
$5k
|
|
| 04/27/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 3,752 shares
@ $1.33, valued at
$5k
|
|
| 03/28/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,839 shares
@ $1.76, valued at
$5k
|
|
| 03/19/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 94,872 shares
@ $0
Paid exercise price by delivering 28,358 shares
@ $1.95, valued at
$55.3k
Granted 200,000 options
@ $1.95, valued at
$390k
|
|
| 02/28/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,255 shares
@ $2.2172, valued at
$5k
|
|
| 01/26/2018 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,134 shares
@ $2.343, valued at
$5k
|
|
| 12/28/2017 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 2,247 shares
@ $2.22, valued at
$5k
|
|
| 11/29/2017 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc. |
| 09/27/2017 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Bought 1,537 shares
@ $3.251, valued at
$5k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2017 |
4
| Mulroy Michael H. (President and CEO) has filed a Form 4 on Asterias Biotherapeutics, Inc.|
Txns:
| Granted 800,000 options to buy
@ $3.7, valued at
$3M
|
|
| 07/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2015 |
4
| Mulroy Michael H. (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 20,000 options to buy
@ $3.57, valued at
$71.4k
|
|
| 08/18/2014 |
4
| Mulroy Michael H. (EVP, Strat. Affairs & GC) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Disposed/sold 16,072 shares
@ $0
Disposed/sold 39,187 shares
@ $0
Disposed/sold 18,000 shares
@ $0
Disposed/sold 51,979 options to buy
@ $14.24, valued at
$740.2k
Disposed/sold 56,250 options to buy
@ $35.78, valued at
$2M
|
|
| 08/13/2014 |
4
| Mulroy Michael H. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Gifted 1,349 shares
@ $0
Sold 5,000 shares
@ $92.3463, valued at
$461.7k
Sold 5,000 shares
@ $92.3232, valued at
$461.6k
|
|
| 08/04/2014 |
4
| Mulroy Michael H. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,304 shares
@ $92.35, valued at
$120.4k
|
|
| 07/14/2014 |
4
| Mulroy Michael H. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $90.9175, valued at
$454.6k
Sold 5,000 shares
@ $90.8649, valued at
$454.3k
Exercised 10,000 options to buy
@ $14.24, valued at
$142.4k
|
|
| 06/12/2014 |
4
| Mulroy Michael H. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $88.5738, valued at
$442.9k
Sold 5,000 shares
@ $88.5751, valued at
$442.9k
Exercised 10,000 options to buy
@ $14.24, valued at
$142.4k
|
|
| 05/14/2014 |
4
| Mulroy Michael H. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Exercised 10,000 shares
@ $14.24, valued at
$142.4k
Sold 5,000 shares
@ $88.0103, valued at
$440.1k
Sold 5,000 shares
@ $87.9713, valued at
$439.9k
Exercised 10,000 options to buy
@ $14.24, valued at
$142.4k
|
|
| 04/14/2014 |
4
| Mulroy Michael H. (See Remarks) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $85.049, valued at
$425.2k
Sold 5,000 shares
@ $85.031, valued at
$425.2k
Exercised 10,000 options to buy
@ $14.24, valued at
$142.4k
|
|
|
|
|